US SB97 | 2019-2020 | 116th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 23-2)
Status: Introduced on January 10 2019 - 25% progression, died in committee
Action: 2019-01-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 10 2019 - 25% progression, died in committee
Action: 2019-01-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
Title
Affordable and Safe Prescription Drug Importation Act
Sponsors
Sen. Bernard Sanders [I-VT] | Sen. Cory Booker [D-NJ] | Sen. Robert Casey [D-PA] | Sen. Tammy Baldwin [D-WI] |
Sen. Richard Blumenthal [D-CT] | Sen. Sherrod Brown [D-OH] | Sen. Maria Cantwell [D-WA] | Sen. Kirsten Gillibrand [D-NY] |
Sen. Kamala Harris [D-CA] | Sen. Margaret Hassan [D-NH] | Sen. Martin Heinrich [D-NM] | Sen. Angus King [I-ME] |
Sen. Patrick Leahy [D-VT] | Sen. Amy Klobuchar [D-MN] | Sen. Joe Manchin [D-WV] | Sen. Jeff Merkley [D-OR] |
Sen. Jack Reed [D-RI] | Sen. Jeanne Shaheen [D-NH] | Sen. Tina Smith [D-MN] | Sen. Debbie Stabenow [D-MI] |
Sen. Tom Udall [D-NM] | Sen. Chris Van Hollen [D-MD] | Sen. Elizabeth Warren [D-MA] | Sen. Sheldon Whitehouse [D-RI] |
Sen. Ron Wyden [D-OR] |
History
Date | Chamber | Action |
---|---|---|
2019-01-10 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB447 (Same As) 2019-01-25 - Referred to the Subcommittee on Health.
HB1478 (Related) 2019-03-01 - Referred to the Subcommittee on Health.
SB1801 (Related) 2019-06-12 - Read twice and referred to the Committee on Finance.
HB1478 (Related) 2019-03-01 - Referred to the Subcommittee on Health.
SB1801 (Related) 2019-06-12 - Read twice and referred to the Committee on Finance.
Subjects
Administrative law and regulatory procedures
Canada
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health
Prescription drugs
Trade restrictions
User charges and fees
Canada
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health
Prescription drugs
Trade restrictions
User charges and fees
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/97/all-info |
Text | https://www.congress.gov/116/bills/s97/BILLS-116s97is.pdf |